Scott Woodward, MS, MA, MBA

Scott Woodward, MS, MA, MBA has 25 years experience in the life science space, beginning his career with AstraZeneca and extending this business development experience to startups globally.

He served as CEO of Nordic Bioscience, Inc. in the United States, a Danish biomarker group targeting the pharmaceutical and biotech industry for drug development and later as SVP of Global Biomarkers for Synarc (now Bioclinica) overseeing their biomarker business activities. For the last decade he worked with a global life science consultancy with its own portfolio of companies (therapeutics, device, diagnostics) whose model was to spin out early stage academic opportunities into new life science companies. Here he served as CBO for several portfolio companies, including therapeutics and blood based diagnostics, with key responsibilities of fundraising, partnering/collaboration with industry, and in/out licensing.

Dr. Woodward maintains his own life science consultancy focused on business development for small to mid sized companies during periods of early development and growth. He is actively involved in numerous accelerators and bioentrepreneurship programs globally, including advisory roles at UC Berkeley’s Skydeck Accelerator and bioentrepreneurship activities at Oxford and Cambridge universities in the UK.

He holds graduate degrees from Eastern Virginia Medical School and Old Dominion University.